Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

American Journal of Pathology

Volumn 159, Issue 3, 2001, Pages 993-1008

  Bussolati, Benedetta ^a   Dunk, Caroline ^a   Grohman, Malcolm ^a   Kontos, Christopher D ^c   Mason, Justin ^b   Ahmed, Asif ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; MATRIGEL; NITRIC OXIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CAPILLARY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; UMBILICAL VEIN;

EID: 0034848647     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61775-0     Document Type: Article

References (45)

1. The biology of vascular endothelial growth factor
2. Vascular endothelial growth factor (VEGF) and its receptors
3. Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor
4. The vascular endothelial growth factor receptor flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
5. Role of VEGF receptor (Flt-1) in mediating calcium dependant nitric oxide release and limiting DNA synthesis in human trophoblast cells
6. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1
7. Failure of blood island formation and vasculogenesis in flk-1 deficient mice
8. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
9. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
10. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
11. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells
12. Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells
13. Nitric oxide released via VEGFR-1 suppresses VEGFR-2 mediated endothelial cell growth and regulates angiogenesis
14. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis
15. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
16. Nitric oxide in the vasculature: Physiology and pathophysiology
17. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P
18. Vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) augments nitric oxide release from quiescent rabbit and human vascular endothelium
19. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
20. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor-induced angiogenesis
21. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
22. Hypoxia down-regulates placenta growth factor whereas fetal growth restriction up-regulates placenta growth factor expression: Molecular evidence for "placental hyperoxia" in intrauterine growth restriction
23. The heme oxygenase system: A regulator of second messenger gases
24. Reorganization of endothelial cord-like structures on basement membrane complex (Matrigel): Involvement of transforming growth factor b
25. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
26. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: An in vivo Matrigel model
27. Selective binding of VEGF121 to one of the three vascular endothelial cell receptors of vascular endothelial cells
28. The vascular endothelial growth factor proteins: Identification of biologically relevant regions by neutralizing monoclonal antibodies
29. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial cell activation, tumour cell expansion and high affinity binding to Flk-1/KDR
30. Vascular endothelial growth factor governs endothelial nitric oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase signaling pathway
31. A novel function of VEGF receptor-2 (KDR): Rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells
32. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
33. A heparin-binding form of placenta growth factor (PIGF-2) is expressed in human umbilical vein endothelial cells and in placenta
34. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development
35. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells
36. Exogenous, basal, and flow induced nitric oxide production and endothelial cell proliferation
37. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor
38. Nitric oxide synthase distribution during implantation in the mouse
39. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
40. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF
41. Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding
42. Flt-1 a receptor for vascular endothelial growth factor, has transforming and morphogenic properties
43. JunB is essential for mammalian placentation
44. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
45. Vascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cells